186 related articles for article (PubMed ID: 25372587)
1. Ten-year evaluation of a Neonatal Screening Program for congenital adrenal hyperplasia.
Nascimento ML; Cristiano AN; Campos Td; Ohira M; Cechinel E; Simoni G; Lee Jv; Linhares RM; Silva PC
Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):765-71. PubMed ID: 25372587
[TBL] [Abstract][Full Text] [Related]
2. Neonatal screening for congenital adrenal hyperplasia.
Barra CB; Silva IN; Pezzuti IL; Januário JN
Rev Assoc Med Bras (1992); 2012; 58(4):459-64. PubMed ID: 22930025
[TBL] [Abstract][Full Text] [Related]
3. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.
Therrell BL; Berenbaum SA; Manter-Kapanke V; Simmank J; Korman K; Prentice L; Gonzalez J; Gunn S
Pediatrics; 1998 Apr; 101(4 Pt 1):583-90. PubMed ID: 9521938
[TBL] [Abstract][Full Text] [Related]
4. A three-year follow-up of congenital adrenal hyperplasia newborn screening.
Pezzuti IL; Barra CB; Mantovani RM; Januário JN; Silva IN
J Pediatr (Rio J); 2014; 90(3):300-7. PubMed ID: 24560529
[TBL] [Abstract][Full Text] [Related]
5. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
González EC; Carvajal F; Frómeta A; Arteaga AL; Castells EM; Espinosa T; Coto R; Pérez PL; Tejeda Y; Del Río L; Segura MT; Almenares P; Robaina R; Fernández JL
Clin Chim Acta; 2013 Jun; 421():73-8. PubMed ID: 23481450
[TBL] [Abstract][Full Text] [Related]
6. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
[TBL] [Abstract][Full Text] [Related]
7. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.
Tsuji A; Konishi K; Hasegawa S; Anazawa A; Onishi T; Ono M; Morio T; Kitagawa T; Kashimada K
BMC Pediatr; 2015 Dec; 15():209. PubMed ID: 26671474
[TBL] [Abstract][Full Text] [Related]
8. [Congenital adrenal hyperplasia newborn screening: Rio de Janeiro experience].
Cardoso CB; Fonseca AA; Oliveira Mde F; Pereira BB; Guimarães MM
Arq Bras Endocrinol Metabol; 2005 Feb; 49(1):112-9. PubMed ID: 16544042
[TBL] [Abstract][Full Text] [Related]
9. Neonatal screening for congenital adrenal hyperplasia: experience and results in Argentina.
Gruñieiro-Papendieck L; Chiesa A; Mendez V; Prieto L
J Pediatr Endocrinol Metab; 2008 Jan; 21(1):73-8. PubMed ID: 18404975
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation.
Kopacek C; Prado MJ; da Silva CMD; de Castro SM; Beltrão LA; Vargas PR; Grandi T; Rossetti MLR; Spritzer PM
J Pediatr (Rio J); 2019; 95(3):282-290. PubMed ID: 29715434
[TBL] [Abstract][Full Text] [Related]
11. Effect of newborn screening for congenital adrenal hyperplasia.
Brosnan PG; Brosnan CA; Kemp SF; Domek DB; Jelley DH; Blackett PR; Riley WJ
Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1272-8. PubMed ID: 10591305
[TBL] [Abstract][Full Text] [Related]
12. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden.
Thil'en A; Nordenström A; Hagenfeldt L; von Döbeln U; Guthenberg C; Larsson A
Pediatrics; 1998 Apr; 101(4):E11. PubMed ID: 9521977
[TBL] [Abstract][Full Text] [Related]
13. Newborn screening for congenital adrenal hyperplasia.
Therrell BL
Endocrinol Metab Clin North Am; 2001 Mar; 30(1):15-30. PubMed ID: 11344933
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of CYP21A2 can optimize the follow-up of positive results in newborn screening for congenital adrenal hyperplasia.
Silveira EL; Elnecave RH; dos Santos EP; Moura V; Pinto EM; van der Linden Nader I; Mendonca BB; Bachega TA
Clin Genet; 2009 Dec; 76(6):503-10. PubMed ID: 19930153
[TBL] [Abstract][Full Text] [Related]
15. The actual incidence of congenital adrenal hyperplasia in Brazil may not be as high as inferred--an estimate based on a public neonatal screening program in the state of Goiás.
Silveira EL; dos Santos EP; Bachega TA; van der Linden Nader I; Gross JL; Elnecave RH
J Pediatr Endocrinol Metab; 2008 May; 21(5):455-60. PubMed ID: 18655527
[TBL] [Abstract][Full Text] [Related]
16. High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland.
Steigert M; Schoenle EJ; Biason-Lauber A; Torresani T
J Clin Endocrinol Metab; 2002 Sep; 87(9):4106-10. PubMed ID: 12213856
[TBL] [Abstract][Full Text] [Related]
17. A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing.
Gong LF; Gao X; Yang N; Zhao JQ; Yang HH; Kong YY
J Pediatr Endocrinol Metab; 2019 Mar; 32(3):253-258. PubMed ID: 30817302
[TBL] [Abstract][Full Text] [Related]
18. Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia.
Hayashi G; Faure C; Brondi MF; Vallejos C; Soares D; Oliveira E; Brito VN; Mendonca BB; Bachega TA
Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):632-7. PubMed ID: 22218447
[TBL] [Abstract][Full Text] [Related]
19. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants.
Güran T; Tezel B; Çakır M; Akıncı A; Orbak Z; Keskin M; Selver Eklioğlu B; Ozon A; Özbek MN; Karagüzel G; Hatipoğlu N; Gürbüz F; Çizmecioğlu FM; Kara C; Şimşek E; Baş F; Aydın M; Darendeliler F
J Clin Res Pediatr Endocrinol; 2020 Sep; 12(3):287-294. PubMed ID: 32157855
[TBL] [Abstract][Full Text] [Related]
20. The presentation of congenital adrenal hyperplasia in an unscreened population.
Conlon TA; Hawkes CP; Brady JJ; Murphy NP
J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1123-1129. PubMed ID: 34167176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
